<b><i>ITPA</i></b> and <b><i>SLC29A1</i></b> Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors

Andrea Lombardi(University of Milan), Felicia Stefania Falvella, Stefania Cheli, Simona Landonio(ASST Fatebenefratelli Sacco), Cristina Mazzali(Luigi Sacco Hospital), Mario U. Mondelli(University of Pavia), Emilio Clementi(Luigi Sacco Hospital), C. Magni(ASST Fatebenefratelli Sacco), Giuliano Rizzardini
Pharmacology
January 1, 2015
Cited by 2


Related Papers